Contractile responses to reactive oxygen species in the canine basilar artery in vitro: Selective inhibitory effect of MCI-186, a new hydroxyl radical scavenger

Acta Neurochirurgica

Volumn 144, Issue 12, 2002, Pages 1305-1310

  Tosaka, Masahiko ^a   Hashiba, Y ^a   Saito, N ^a   Imai, H ^a   Shimizu, T ^a   Sasaki, T ^a   Doczi T ^b   Buki A ^b   Seifert, V ^b  

^a GUNMA UNIVERSITY   (Japan)

^b NONE

Author keywords

Canine basilar artery; MCI 186; Reactive oxygen species; Subarachnoid haemorrhage

Indexed keywords

CATALASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; NORPHENAZONE; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; BASILAR ARTERY; BRAIN VASOSPASM; CONTROLLED STUDY; DOG; DRUG EFFECT; FEMALE; IN VITRO STUDY; INCUBATION TIME; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIPYRINE; BASILAR ARTERY; DISEASE MODELS, ANIMAL; DOGS; FEMALE; FREE RADICAL SCAVENGERS; HYDROGEN PEROXIDE; HYDROXYL RADICAL; MALE; OXIDANTS; REACTIVE OXYGEN SPECIES; SUPEROXIDES; VASOSPASM, INTRACRANIAL;

EID: 0036460092     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00701-002-1020-8     Document Type: Article

References (31)

1. Abe K, Yuki S, Kogure K (1988) Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19: 480-485
2. Asano T (1999) Oxyhemoglobin as the principal cause of cerebral vasospasm: A holistic view of its actions. Crit Rev Neurosurg 24: 303-318
3. Asano T, Matsui T (1999) Antioxidant therapy against cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cell Mol Neurobiol 19: 31-44
4. Brodie BB, Axelrod J, Shore PA, Udenfriend S (1954) Ascorbic acid in aromatic hydroxylation: 2. Products formed by reaction of substrates with ascorbic acid, ferrous ion, and oxygen. J Biol Chem 208: 741-750
5. Connor HE, Feniuk W (1987) Role of endothelium in haemoglobin-induced contraction of dog basilar artery. Eur J Pharmacol 140: 105-108
6. Dorsch NWC, King MT (1994) A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage. J Clin Neurosci 1: 19-26
7. Epstein AM, Throckmorton D, Brophy CM (1997) Mitogen-activated protein kinase activation: An alternate signaling pathway for sustained vascular smooth muscle contraction. J Vasc Surg 26: 327-332
8. Grover AK, Samson SE, Misquitta CM, Elmoselhi AB (1997) Effects of peroxide on contractility of coronary artery rings of different sizes. Mol Cell Biochem 194: 159-164
9. Ignarro LJ, Byrns RE, Buga GM, Wood KS, Chaudhuri G (1988) Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: Use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation. J Pharmacol Exp Ther 244: 181-189
10. Ito S, Ueno K, Mitarai A, Sasaki K (1993) Evidence for hydroxyl radicals as an active species generated from Udenfriend's reagent. J Chem Soc Perkin Trans 2: 255-259
11. 2-induced contraction in pulmonary artery. Am J Physiol 272: H2686-H2692
12. Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47: 469-474
13. Mizuno A, Umemura K, Nakashima M (1998) Inhibitory effect of MCI-186, a free radical scavenger, on cerebral ischemia following rat middle cerebral artery occlusion. Gen Pharmacol 30: 575-578
14. Mori T, Nagata K, Town T, Tan J, Matsui T, Asano T (2001) Intracisternal increase of superoxide anion production in a canine subarachnoid hemorrhage model. Stroke 32: 636-642
15. Nakagomi T, Yamakawa K, Tsubaki S, Sasaki T, Takakura K (1990) Effect of new free radical scavenger, MCI-186, on experimental cerebral vasospasm. Proceedings of the IVth International Conference on Cerebral Vasospasm, University of Tokyo Press, Tokyo, pp 141-142
16. Nappi AJ, Vass E (1997) Comparative studies of enhanced iron-mediated production of hydroxyl radical by glutathione, cysteine, ascorbic acid, and selected catechols. Biochim Biophys Acta 29: 295-302
17. Oishi R, Itoh Y, Nishibori M, Watanabe T, Nishi H, Saeki K (1989) Effect of MCI-186 on ischemia-induced changes in monoamine metabolism in rat brain. Stroke 20: 1557-1564
18. 2+ and MLC20 phosphorylation-independent contraction in intact and permeabilized vascular muscle. Am J Physiol Heart Circ Physiol 279: H1185-H1193
19. 2-induced arterial muscle contraction. Am J Physiol Heart Circ Physiol 279: H1194-H1200
20. Rasmussen H, Takuwa Y, Park S (1987) Protein kinase C in the regulation of smooth muscle contraction. FASEB J 1: 177-185
21. Rodriguez-Martinez MA, Garcia-Cohen EC, Baena AB, Gonzalez R, Salaices M, Marin J (1998) Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanism involved. Br J Pharmacol 125: 1329-1335
22. 2. Life Sci 66: PL291-PL296
23. Tabrizchi R (2000) Edaravone Mitsubishi-Tokyo. Curr Opin Investig Drugs 1: 347-354
24. Tanaka M (2002) [Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent.] Nippon Yakurigaku Zasshi 119: 301-308
25. Tosaka M, Okajima F, Hashiba Y, Saito N, Nagano T, Watanabe T, Kimura T, Sasaki T (2001) Sphingosine-1-phosphate contracts canine basilar arteries in vitro and in vivo: Possible role in pathogenesis of cerebral vasospasm. Stroke 32: 2913-2919
26. Treggiari-Venzi MM, Suter PM, Romand JA (2001) Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: A problem of neurointensive care. Neurosurgery 48: 249-262
27. Udenfriend S, Clark CT, Axelrod J, Brodie BB (1954) Ascorbic acid in aromatic hydroxylation: 1. A model system for aromatic hydroxylation. J Biol Chem 208: 731-739
28. Watanabe T, Yuki S, Egawa M, Nishi H (1994) Protective effects of MCI-186 on cerebral ischemia: Possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 268: 1597-1604
29. Watanabe T, Egawa M (1994) Effects of an antistroke agent MCI-186 on cerebral arachidonate cascade. J Pharmacol Exp Ther 271: 1624-1629
30. Yamamoto Y, Kuwahara K, Watanabe K, Watanabe K (1996) Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one. Radox Report 2: 333-338
31. 2+]i in canine cerebral arterial smooth muscle: Participation of cellular signaling pathways. Naunyn Schmiedebergs Arch Pharmacol 360: 646-653